4//SEC Filing
Genexine Inc. 4
Accession 0001209191-21-048448
CIK 0001509261other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 5:24 PM ET
Size
11.1 KB
Accession
0001209191-21-048448
Insider Transaction Report
Form 4
Rezolute, Inc.RZLT
Genexine Inc.
10% Owner
Transactions
- Conversion
Series AA Preferred Stock
2019-04-26$10.00/sh−1,250,000$12,500,000→ 0 totalExercise: $0.22→ Common Stock (56,818,175 underlying) - Conversion
Common Stock
2019-04-26+56,818,175→ 56,818,175 total - Purchase
Common Stock
2019-07-23$0.29/sh+34,482,758$10,000,000→ 91,300,933 total
Footnotes (4)
- [F1]Reporting Person acquired 1,250,000 shares of Issuer's Series AA Preferred Stock on January 30, 2019. Each share of the Issuer's Series AA Preferred Stock is convertible into shares of the Issuer's Common Stock at a ratio of 45.45454 shares of Common Stock for one share of Series AA Preferred Stock ("Conversion Rate") at the holder's election and has no expiration date. The Series AA Preferred Stock will automatically convert, at the Conversion Rate, into Common Stock (i) at any time upon the vote or consent of the holders of two thirds of the voting power of the then outstanding Series AA Preferred Stock or (ii) the amendment to Issuer's Certificate of Incorporation to increase the number of shares of Common Stock authorized to be issued to at least 500,000,000 shares of Common Stock.
- [F2]Upon the filing of Issuer's amendment to Certificate of Incorporation on April 26, 2019, which amendment increased the authorized number of shares of Common Stock of the Issuer to 500,000,000, each share of Series AA Preferred Stock automatically converted into shares of the Issuer's Common Stock at the Conversion Rate.
- [F3]Issuer granted Reporting Person a call option whereby the earlier of, (i) December 31, 2020 and (ii) the date when Issuer asks Reporting Person for further financing, Reporting Person may elect to purchase up to $10,000,000 worth of shares of the Issuer's Common Stock at a purchase price equal to the greater of: (i) $0.29 per share or (ii) 75% of the volume weighted average closing price of the Issuer's Common Stock during the thirty (30) consecutive trading days prior to the date of the notice. Pursuant to a Purchase Agreement for Shares of Common Stock dated July 23, 2019, Reporting Person exercised the full call option to purchase Common Stock.
- [F4]Such amount now represents 1,826,019 shares of common stock after taking into account the 50:1 reverse stock split effected October 7, 2020.
Documents
Issuer
Rezolute, Inc.
CIK 0001509261
Entity typeother
IncorporatedKorea, Republic of
Related Parties
1- filerCIK 0001834377
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 5:24 PM ET
- Size
- 11.1 KB